ストックスクリーナーアプリを入手
70.59
2.15%
-1.55
アフターアワーズ：
70.59
Corcept Therapeutics Inc (CORT) 最新ニュース
Here's How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 5 Years - Benzinga
Corcept Therapeutics (NASDAQ:CORT) Is Posting Promising Earnings But The Good News Doesn’t Stop There - Yahoo Finance
Why Corcept Therapeutics (CORT) Is Among the Best Performing Healthcare Stocks to Buy Now - Yahoo Finance
11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey
Investor Network: Corcept Therapeutics Incorporated. to Host Earnings Call - ACCESS Newswire
Corcept Therapeutics chief development officer sells $524,652 in stock - Investing.com Australia
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT) - GuruFocus
High- and Low-Grade Serous Ovarian Cancer Market is Predicted to Grow at a CAGR of 7.9% During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript - Insider Monkey
CORT's Q1 Earnings In Line With Estimates, Revenues Lag, Shares Fall - MSN
Corcept Therapeutics price target lowered to $135 from $150 at Truist - Yahoo Finance
Corcept Therapeutics (NasdaqCM:CORT) Reports US$21M Q1 Net Income Lowers EPS - Yahoo Finance
Corcept Therapeutics (CORT) Faces Price Target Cut Amid Revenue Concerns | CORT Stock News - GuruFocus
Assessing Corcept Therapeutics: Insights From 9 Financial Analysts - Benzinga
Truist Cuts Price Target on Corcept Therapeutics to $135 From $150, Keeps Buy Rating - marketscreener.com
H.C. Wainwright cuts Corcept Therapeutics target to $145 By Investing.com - Investing.com Nigeria
Corcept Therapeutics (CORT) Receives Revised Price Target from A - GuruFocus
Corcept Therapeutics (CORT) Receives Revised Price Target from Analyst | CORT Stock News - GuruFocus
Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Pr - GuruFocus
Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Price Target | CORT Stock News - GuruFocus
Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Es - GuruFocus
Corcept Therapeutics (CORT) Pre-Earnings Options Activity Sugges - GuruFocus
Corcept Therapeutics Inc (CORT) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges - GuruFocus
Decoding Corcept Therapeutics Inc (CORT): A Strategic SWOT Insig - GuruFocus
Corcept Therapeutics Reports Q1 2025 Financial Results - TipRanks
Corcept Therapeutics Stock Jumps On Record Prescription Volume: Retail Sentiment Soars - MSN
Corcept: Q1 Earnings Snapshot - MySA
Corcept Therapeutics (CORT) Anticipates Future Growth Amid Reven - GuruFocus
Corcept Therapeutics (CORT) Set to Announce Q1 Earnings - GuruFocus
Earnings call transcript: Corcept Therapeutics Q1 2025 earnings beat expectations By Investing.com - Investing.com UK
Corcept Therapeutics (CORT) Meets Q1 Earnings Estimates - Yahoo Finance
Corcept (NASDAQ:CORT) Misses Q1 Sales Targets, Stock Drops - Yahoo Finance
Corcept Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CORCEPT THERAPEUTICS Earnings Results: $CORT Reports Quarterly Earnings - Nasdaq
Corcept Therapeutics Q1 Earnings Decrease, Revenue Rises -- Shares Fall After Hours - marketscreener.com
Corcept Therapeutics (CORT) Reports Q1 Revenue Miss | CORT Stock News - GuruFocus
Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Estimates, Revenue of $157.2M Misses Expectations - GuruFocus
Corcept Therapeutics misses revenue estimates, stock falls By Investing.com - Investing.com UK
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE | CORT Stock News - GuruFocus
Corcept Earnings: $157M Revenue and Breakthrough ALS Survival Data Spark Pipeline Momentum - Stock Titan
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Bluefield Daily Telegraph
Corcept Therapeutics (CORT): Among Billionaire Jim Simons’ RenTech’s Small-Cap Stock Picks with Huge Upside Potential - Insider Monkey
Corcept (CORT) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Is Corcept Therapeutics Inc. (NASDAQ:CORT) the Best Growth Stock to Buy for the Next 3 Years? - Insider Monkey
BlackRock, Inc. Reduces Stake in Corcept Therapeutics Inc - GuruFocus
Corcept Therapeutics to Report Q1 Earnings: What's in the Cards? - Nasdaq
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS - GuruFocus
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL | CORT Stock News - GuruFocus
CORCEPT THERAPEUTICS TO ANNOUNCE FIRST QUARTER FINANCIAL RESULTS, PROVIDE CORPORATE UPDATE AND HOST CONFERENCE CALL - Business Wire
3 Healthcare Stocks That Concern Us - Yahoo Finance
Here's How Much $1000 Invested In Corcept Therapeutics 10 Years Ago Would Be Worth Today - Benzinga
March sees multiple phase III successes, boosting Corcept and Mineralys - BioWorld MedTech
Is Corcept Therapeutics Incorporated (CORT) Among the Best Guru Stocks to Buy According to Wall Street Analysts? - MSN
3.01%
大文字化:
|
ボリューム (24 時間):